On May 24th, three products, namely, the monkey pox virus nucleic acid detection kit (RT-PCR method), the monkey pox virus antigen detection kit (colloidal gold method) and the monkey pox virus antibody detection kit (colloidal gold method), developed by Nanjing Ji Shen Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Ji Shen Medicine") obtained the EU CE certificate at the same time. The simultaneous approval of these products means that these kits can be sold in EU countries and countries that recognize EU CE certification.
Nanjing Ji Shen medicine is controlled by oriental genes. Nanjing Ji Shen Pharmaceutical Technology Co., Ltd. was established on 20 18-08-02, with the legal representative of Mix, the registered capital of RMB 5 million, the unified social credit code of 913201x09de0u, and the enterprise address is located in Di Wei, Xianlin University Town, Xianlin Street, Qixia District, Nanjing. Biotechnology research and development, technical consultation, technical service and technology transfer.